Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Calendar
  • Grants
  • About Akademiliv
Genrebild från iStock.

Drug combination increases susceptibility to cytostatic treatments in cases of severe neuroblastoma

7 January, 2021 Leave a Comment

NEW STUDY. Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs. In a new study in the journal Cancer Research, they describe how a two small molecule-based drug combination likely inhibit the tumor’s growth.

Sanhita Mitra (to the left), first author of the paper in Cancer Research, was a PhD student during this study, now Post Doc. Assistant Professor Tanmoy Mondal (to the right) also made important contributions to the study.

Neuroblastoma is the most common form of childhood cancer, derived from the peripheral nervous system, i.e., the part of the nervous system that is not the brain or spinal cord. The disease can occur in the chest, neck, abdomen and adrenal glands and can also spread to the spine. Symptoms include general aches, anemia and skeletal pain.

The average age of children at diagnosis is 17 months, and it is rarely diagnosed over the age of five. The milder form of neuroblastoma can, in some cases, self-heal, while the more aggressive form is the deadliest form of childhood cancer. Treatment is successful in less than half of these cases.

A long noncoding RNA molecule influences tumor suppressor gene expression

Chandrasekahr Kanduri (photo: Margareta G Kubista)

Central molecule in the study is the p53 gene. The p53 gene is often mutated in other cancer forms but rarely in neuroblastoma. When it is not mutated, p53 codes for a protein that inhibit the growth of cancer. This study shows that how the expression levels of a long non-coding RNA molecule influences the function of p53 protein. “Interestingly, this long non-coding RNA increases p53 function in the nucleus to make tumor cells more susceptible to cytostatic treatment,” says Chandrasekhar Kanduri, professor of medical genetics specialized in RNA epigenetics at the University of Gothenburg.

Two small molecule-based drug combination for neuoblastoma

The RNA molecule NBAT1 changes the function of the protein CRM1, which transports p53 from nucleus to cytoplasm. NBAT1 also helps in keeping the p53 protein in the nucleus to increase p53 controlled gene expression. Based on these findings, the research group tested a new treatment that combines the drugs Selinexor and Nutlin-3a. Both drugs are currently undergoing clinical trials for cancer treatments but not for neuroblastoma. Selinexor restores p53’s ability to inhibit cancer growth and Nutlin-3a inhibits the breakdown of p53.

“The combination treatment blocks the protein export function of CRM1, which leads to p53 accumulation in the cell nucleus. This treatment increases p53 dependent functions, such as DNA damage and cell death. We think that combining these two drugs with current treatment strategies may allow us to cure hard-to-treat neuroblastomas.”

The results are promising, but they are based on preclinical studies of cancer cell lines and mouse models (xenografts) and more research is needed before the findings can be translated into treatment. These laboratory results have been partly validated with the neuroblastoma patient data, obtained in collaboration with the researchers at Karolinska Institute. Thus, this study has clearly opened the way for a potential new treatment strategy for high-risk neuroblastoma patients.

Title: Subcellular distribution of p53 by the p53-responsive lncRNA NBAT1 determines chemotherapeutic response in neuroblastoma, https://doi.org/10.1158/0008-5472.CAN-19-3499

TEXT: ELIN LINDSTRÖM

 

By: Elin Lindström
Tagged With: institutionen för biomedicin

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Add your own events in the Akademiliv Calendar

Webinar: SAGE Research Methods

Forskarsnabben – full autumn program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life. Start January 27.
English version further down in the document.

The novel coronavirus – University-wide information on the Staff Portal

Read up-tp-date information regarding how effects of the pandemic are handled at the university.

The entrance doors are locked

Due to new restrictions and decisions, all entrances are locked. For daytime access, use your GU card.

We are building at Medicinareberget

You will now find comprehensive information on construction projects that affect the Sahlgrenska Academy in the Staff Portal.

Lunch menus

Café & restaurang Anatomen

Gastronomen på SU

Lunchen.nu

Lyktan lunchservering

Lustgården på Änggårdsbacken

Café Anne Dahl

More news

Continued stricter regulations at University of Gothenburg

22 January, 2021

COVID-19. The stricter restrictions that currently exist at the University of Gothenburg have been extended until further notice. This means that …  

Karl Swedberg discusses study in NEJM on increasing contractility by stimulation with pharmaceutical agent

20 January, 2021

COMMENTARY. Karl Swedberg, a senior professor and a renown international researcher in heart failure, has written an editorial in the latest …  

SEK 13.6 million for childhood cancer research in Gothenburg

19 January, 2021

GRANTS. In its latest funding round, the Swedish Childhood Cancer Fund awarded a total of SEK 146 million for Swedish research, which is a new …  

Many advantages with double degrees – a well-functioning collaboration enabled her defense of dissertation

19 January, 2021

DOCTORAL EDUCATION. The first doctoral student admitted to doctoral studies at both Sahlgrenska Academy and KU Leuven has now defended her …  

New principle for cancer treatment shows promising effect

18 January, 2021

NEW STUDY. A new type of inhibitor that interferes with mitochondrial function in cancer cells has been developed in a collaboration involving …  

Justin Schneiderman’s new assignment supports management in AI developments

18 January, 2021

AI NYTT. We can use artificial intelligence for many things, including for organizing otherwise unmanageable amounts of data or developing …  

Regarding media attention around exam in the university’s examination halls

18 January, 2021

EXAMINATION. Media is reporting that about 150 students at the University of Gothenburg during the current pandemic will gather today Friday, to …  

Construction information Medicinareberget – Walls for Natrium’s first floor soon in place

18 January, 2021

CONSTRUCTION INFORMATION. Akademiliv provides information on the construction of Natrium on Medicinareberget for the period weeks 51-02 (December …  

Researchers identify a new biomarker for the childhood cancer neuroblastoma

15 January, 2021

NEW STUDY. In collaboration with researchers in the Netherlands and Belgium, researchers at the University of Gothenburg have now shown that …  

Researchers can begin applying to use SCAPIS data from March 17

14 January, 2021

RESEARCH. The launch of unique SCAPIS is approaching. SCAPIS is a bank of data, blood samples and bioimages from 30,000 participants that will be …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström Claessen is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen